The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, represents a complex complicated synthetic process. Initial routes focused on peptide fragment coupling, utilizing solid-phase https://emilyfcpv622057.smblogsites.com/40806561/synthesis-and-study-uses-of-retatrutide